- Home
- XXII vs INBS Comparison
XXII vs INBS Comparison
Compare XXII & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- INBS
- Stock Information
- Founded
- XXII 1998
- INBS 2016
- Country
- XXII United States
- INBS United States
- Employees
- XXII N/A
- INBS N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- INBS Medical Specialities
- Sector
- XXII Health Care
- INBS Health Care
- Exchange
- XXII Nasdaq
- INBS Nasdaq
- Market Cap
- XXII 6.2M
- INBS 6.4M
- IPO Year
- XXII N/A
- INBS N/A
- Fundamental
- Price
- XXII $0.88
- INBS $0.69
- Analyst Decision
- XXII
- INBS
- Analyst Count
- XXII 0
- INBS 0
- Target Price
- XXII N/A
- INBS N/A
- AVG Volume (30 Days)
- XXII 1.3M
- INBS 265.2K
- Earning Date
- XXII 11-04-2025
- INBS 11-12-2025
- Dividend Yield
- XXII N/A
- INBS N/A
- EPS Growth
- XXII N/A
- INBS N/A
- EPS
- XXII N/A
- INBS N/A
- Revenue
- XXII $20,346,000.00
- INBS $3,292,042.00
- Revenue This Year
- XXII N/A
- INBS $778.48
- Revenue Next Year
- XXII $126.57
- INBS N/A
- P/E Ratio
- XXII N/A
- INBS N/A
- Revenue Growth
- XXII 16.98
- INBS 3.26
- 52 Week Low
- XXII $0.78
- INBS $0.64
- 52 Week High
- XXII $336.89
- INBS $2.75
- Technical
- Relative Strength Index (RSI)
- XXII 28.09
- INBS 30.21
- Support Level
- XXII $0.84
- INBS $0.64
- Resistance Level
- XXII $0.95
- INBS $0.69
- Average True Range (ATR)
- XXII 0.10
- INBS 0.05
- MACD
- XXII -0.03
- INBS 0.00
- Stochastic Oscillator
- XXII 8.61
- INBS 17.04
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.